Navigation Links
Cephalon Acquires Controlling Interest in Arana Therapeutics
Date:5/20/2009

Cephalon now has a relevant interest in more than 50 percent of Arana shares

FRAZER, Pa., May 20 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that its wholly-owned subsidiary, Cephalon International Holdings, Inc., now has a relevant interest in 50.1 percent of Arana Therapeutics Limited's issued shares and has declared its Offer for the company free from all outstanding conditions.

As a result, under the previously announced accelerated payment terms, Arana shareholders who have already accepted the Offer will be sent their cash consideration within five business days, while those who accept after today's date will be sent their cash consideration within five business days after Cephalon receives their valid acceptance.

Cephalon Chairman and CEO, Frank Baldino Jr., Ph.D., said, "We are pleased to have achieved a controlling interest in Arana. The acquisition of Arana is an important part of our long-term strategy to expand our technology base. We look forward to advancing their pipeline in inflammatory diseases and cancer."

The Offer will remain open for acceptances until 7:00pm (Sydney time) on 1 June 2009, its scheduled close, unless extended.

Cephalon is offering A$1.40 per Arana Share. Under the terms of the Cephalon Offer, the amount of the Arana special dividend of 5 Australian cents per Arana share will be set off against the Offer price, meaning accepting Arana shareholders will receive cash consideration of A$1.35 per Arana share from Cephalon. If Cephalon obtains a relevant interest in 90% of Arana shares during the Offer period, accepting Arana shareholders will receive cash consideration of A$1.40 per Arana share from Cephalon.

About Arana Therapeutics Limited

Arana is a biopharmac
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cephalon Quarterly Conference Call Invitation
2. Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
3. Cephalon Quarterly Conference Call Invitation
4. Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference
5. Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication
6. Video: Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
7. Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
8. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
9. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
10. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
11. Cephalon Conference Call Invitation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... testosterone falls below normal levels are more likely to ... heart disease and type 2 diabetes. A new simple ... testing and possible treatment is described in an article ... publication from Mary Ann Liebert, Inc., publishers. The article ... Health website at http://www.liebertpub.com/jmh . ...
(Date:4/23/2014)... science, "simple and accessible detection methods that can ... resolution of a single cell inside that population ... engineer Chang Lu. , In the Royal Society ... has announced that he and his coworkers have ... location of a protein ( Chem. Sci. , ...
(Date:4/23/2014)... of probiotics, antioxidants and other nutritional compounds, more and ... is getting in on the action. But legitimate skepticism ... industry is responding with clinical research to shore up ... Chemical & Engineering News (C&EN), the weekly news ... Bomgardner, a senior editor at C&EN, writes that about ...
(Date:4/23/2014)... country as wealthy as the United States, it may come ... have access to adequate food due to lack of money ... Recent research at the University of Illinois using data from ... the seniors who are dealing with hunger are also facing ... percent of Americans over age 60 faced the threat of ...
(Date:4/23/2014)... a researcher from the Cancer Science Institute of Singapore ... identified the cancer specific stem cell which causes gastric ... new drugs for the treatment of this disease and ... by Dr Chan Shing Leng, Research Assistant Professor at ... cancer-specific variant of a cell surface protein, CD44v8-10, marks ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3
... ... to electronic medical records for attendees of the Michigan Osteopathic Association’s (MOA) 111th Annual ... ... Secure-24 and ATMP offered leadership and guidance about the transition from paper to electronic ...
... ... recently appointed industry leader Steve Potts as CEO. Dr. Potts brings strong business experience ... ... Biosciences LLC, a provider of digital pathology services, announced that Steven Potts ...
... 24, 2010 Genetic variation due to DNA mutation ... well as a contributing factor to disease. However, ... understood. In a report published online today in ... identified intrinsic properties of DNA that influence mutation rate, ...
... restricts the supply of blood to tumours has been developed ... vaccine slows the growth of breast cancer tumours in mice. ... a few millimetres it must be able to stimulate the ... supply of oxygen and nutrients. Drugs that prevent the growth ...
... lagging behind other developed countries, study finds , MONDAY, ... children under the age of 5 appears to be ... deaths -- than the latest mortality estimates released by ... number-crunching conducted by researchers at the Institute for Health ...
... , ... Company offers affordable expert facilitation, project management support and peer-to-peer learning opportunities to ... ... the American Academy of Family Physicians, today announced a new service offering aimed ...
Cached Medicine News:Health News:ATMP and Secure-24 Offer Physicians Leadership and Guidance for Electronic Medical Records 2Health News:ATMP and Secure-24 Offer Physicians Leadership and Guidance for Electronic Medical Records 3Health News:Digital Pathology Services Firm Flagship Biosciences Appoints New CEO 2Health News:Digital Pathology Services Firm Flagship Biosciences Appoints New CEO 3Health News:New research indicates that DNA sequence itself influences mutation rate 2Health News: A new cancer vaccine starves tumors of blood 2Health News:Global Death Rate for Children Lower Than Thought 2Health News:TransforMED Launches New Service Offering to Accelerate Medical Home Adoption in Small Practices 2Health News:TransforMED Launches New Service Offering to Accelerate Medical Home Adoption in Small Practices 3Health News:TransforMED Launches New Service Offering to Accelerate Medical Home Adoption in Small Practices 4
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
(Date:1/14/2014)... 14, 2014 Animal Emergency Critical Care, a LifeCentre partner practice, ... is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is a ... Dr. Cole Taylor , are avid scuba divers. "As altitude ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... , , LOUISVILLE, Colo. , Feb. ... to give a boom to body contouring practices in the ... VASER® Lipo System – comes this non-invasive ultrasound and massage ... only system that has a specific lymphatic massage component with ...
... , ATLANTA , ... ( Duarte, Calif. ), a leading research and treatment center ... to implement an electronic interface that links its TomoTherapy® Hi-Art® ... management system. The connection enables communication between the MOSAIQ and ...
Cached Medicine Technology:Body Contouring Gets Refined with MedSculpt 2City of Hope Testing New Communication Link Between Cancer Therapy System and Elekta Electronic Medical Record System 2City of Hope Testing New Communication Link Between Cancer Therapy System and Elekta Electronic Medical Record System 3
... better. How can one of the leading ... becoming more convenient to use in all ... TwinFix Suture Anchor with Needles combines the ... and timesaving anchor inserter and needle delivery ...
... The TACIT Threaded Anchor ... used in craniofacial and ... easy, secure tissue reattachment ... suspension. The small size ...
The Mini Anchor is an exceptionally strong, versatile anchor. This anchor comes in either a load-your-own or QUICKANCHOR format, preloaded on either 2/0 or 0 ETHIBOND EXCEL suture with swaged needles...
... FASTIN RC is a ... for rotator cuff procedures. The ... a small core to optimize ... independent suture channels to prevent ...
Medicine Products: